Emerging Technologies in Continuous IOP Monitoring - Summary - MDSpire
Feature

Emerging Technologies in Continuous IOP Monitoring

Wearable and implantable devices offer new data on pressure variability, though barriers to routine use persist.

Share

Wearable and implantable devices are transforming intraocular pressure (IOP) monitoring in glaucoma management, addressing limitations of traditional tonometry that capture only brief, isolated readings. Continuous monitoring technologies such as contact lens-based sensors (CLBS) and implantable microelectromechanical systems (bioMEMS) enable tracking IOP patterns around the clock, revealing diurnal variations and nocturnal peaks that inform treatment strategies. These innovations promise to enhance risk stratification and individualize patient management, despite barriers like device adoption and clinical workflow integration.

Original Source(s)

Emerging Technologies in Continuous IOP Monitoring

  • by Khushi Saigal, BA, Rachel Chapman, Samantha Goldburg, MD, Mary Qiu, MD,

  • May 1, 2026

Related Content

GA Gene Therapy Interest Increases

Phase I trial results of PulseSight Therapeutics’ PST-611 to be presented at ARVO 2026

  • May 1, 2026

  • 2 min
Ocugen GA Trial Advances Toward Phase 3

Ocugen reports positive Phase 2 data for its OCU410 gene therapy in geographic atrophy

  • May 1, 2026

  • 3 min
TULIP: A New Approach to IOP Reduction

Low-power ultrasound biomodulation may offer a noninvasive, repeatable strategy to lower IOP without tissue destruction.